EU - OHE - Page 71

Office of Health Economics

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Policy, Organisation and…
Health Policy and Regulation

Costs of Mental Care

Drug Development/R&D
Economics of Innovation

Science, Industry in the State

Policy, Organisation and…
Health Policy and Regulation

Factors Which May Affect Expenditure on Health

Drug Development/R&D
Economics of Innovation
Research Funding

Finance of Medical Research

Health Care Systems
Policy, Organisation and…
Health Policy and Regulation

Costs of Medical Care

Health Data and Statistics
Policy, Organisation and…
Epidemiology and Public Health

New Frontiers in Health

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Saudi Arabia Slovak Republic Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Lishani Ramanayake Sukanya Subramaniyan Brittany Darrow Henry Fong Yi Wang Chittawan Poonsiri Manit Sittimart Sarin Kc Hannah Hussain Dr. Sabine Vogler

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

Value, Affordability, and…
Cancer

Using QALYs in Cancer: Review of the Methodological Limitations

Measuring and Valuing Outcomes
Determining Value

Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

Antimicrobial Resistance (AMR)
Economics of Innovation
Generics

New Drugs to Tackle Antimicrobial Resistance: EU Policy Options

Real World Evidence (RWE)

Enhancing the Benefits from Biomedical and Health Research Spillovers

Health Care Systems
Policy, Organisation and…
Healthcare Delivery

US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?

Drug Development/R&D
Economics of Innovation
Innovation

Innovation in Medicines: Can We Value Progress?

EQ-5D and PROMs
Measuring and Valuing Outcomes
Quality of Care

Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making

Measuring and Valuing Outcomes
Clinical Outcomes

Measuring Health Output, Productivity and Equity: Future Challenges

Health Policy and Regulation

Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries

Value-Based Pricing
Measuring and Valuing Outcomes
Determining Value

Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?

Real World Evidence (RWE)
Economics of Innovation
Research Funding

Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending

Health Care Systems
Policy, Organisation and…
Health Policy and Regulation

How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England

Health Technology Assessment…
Economics of Innovation

Deliberative Processes in Decisions about Health Care Technologies

Health Technology Assessment…

American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis

Drug Development/R&D
Economics of Innovation

The Impact of Health Technology Assessment on Drug Development

Health Technology Assessment…
Value, Affordability, and…
Cancer

Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Twitter

Facebook

Copy

Share on Mastodon

Enter your Mastodon instance URL (optional)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!

News & Insights

Latest Research & Publications

Costs of Mental Care

Science, Industry in the State

Factors Which May Affect Expenditure on Health

Pharmacist in Society

Pattern of Diabetes

Finance of Medical Research

Costs of Medical Care

New Frontiers in Health

All Publications

Filter results by

Using QALYs in Cancer: Review of the Methodological Limitations

Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

New Drugs to Tackle Antimicrobial Resistance: EU Policy Options

Enhancing the Benefits from Biomedical and Health Research Spillovers

US Healthcare Reform: Monumental Health System Transformation or Fatally Flawed Compromise?

Innovation in Medicines: Can We Value Progress?

Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making

Measuring Health Output, Productivity and Equity: Future Challenges

Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries

Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?

Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending

How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England

Deliberative Processes in Decisions about Health Care Technologies

American Exceptionalism and American Health Care: Implications for the US Debate on Cost-Effectiveness Analysis

The Impact of Health Technology Assessment on Drug Development

Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience

Share on Mastodon